Clostridioides difficile toxin A, CROP domain (TcdA CROP) (TcdA CROP)

Clostridioides difficile toxin A (TcdA) is a potent exotoxin and a major virulence factor responsible for the clinical manifestations of C. difficile infection (CDI) [1]. The C-terminal Combined Repetitive Oligopeptides (CROP) domain is a critical structural component that functions as the receptor-binding region of the toxin [2]. It consists of multiple repeating units that recognize and bind to specific carbohydrate motifs on the surface of intestinal epithelial cells, facilitating the toxin's entry via receptor-mediated endocytosis [3]. Once internalized, the toxin's enzymatic domain inactivates host Rho GTPases, leading to the disruption of the actin cytoskeleton, loss of tight junctions, and massive fluid secretion and inflammation [1]. Because the CROP domain is essential for host cell attachment, it serves as a primary target for neutralizing antibodies and vaccine development [4]. Drugs like actoxumab (MK-3415) are designed to bind to this domain, preventing the toxin from interacting with host receptors and thereby mitigating the damage to the colonic mucosa [2]. While actoxumab was developed to target this domain, clinical trials have shown that neutralizing TcdB is often more critical for preventing recurrence, though TcdA remains a significant therapeutic target in combination therapies [2].

Other names

Clostridium difficile toxin A, CROP domainTcdA receptor-binding domainEnterotoxin A C-terminal domainC-terminal repetitive oligopeptides of TcdATcdA RBD

Neutralization of toxin binding to host cell receptors by binding to the CROP domain and preventing attachment to intestinal epithelial cells.